Novella Innovative Technology

Company Overview

Snapshot

Founded in February 2022 by Kobi Avidan, Itay Dana, and Shimrit Bar-El, Novella Innovative Technology operates with 1–10 employees. The company has raised $600,000 across one funding round. In March 2026, Novella Innovative Technology appointed.

Business overview

Novella Innovative Technology specializes in plant cell cultures for the mass production of cell suspensions containing secondary metabolites. The company's technology eliminates the need for extensive land and water resources, enabling production in controlled, sterile environments. This approach ensures consistent nutritional and biological effectiveness, free from climate or supply-chain limitations. Novella serves the Agriculture & Food Technologies sector, focusing on sustainable farming, biochemical compounds, and nutrition, with applications in pharmaceuticals and food retail.

Strategic signal

In May 2026, Novella Innovative Technology was reported to be raising $16 million to support companies in insuring complex missions, indicating a significant strategic pivot or expansion beyond its initial focus on plant-cell-based ingredients. This development suggests the company is exploring new market opportunities or leveraging its core technology in novel applications, signaling potential for diversified growth and increased market reach to investors.

Company Intelligence Q&A

When was Novella Innovative Technology founded?

Novella Innovative Technology was founded in February 2022.

Who are the founders of Novella Innovative Technology?

Novella Innovative Technology was founded by Kobi Avidan, Itay Dana, and Shimrit Bar-El.

What significant leadership change occurred at Novella Innovative Technology?

In March 2026, Novella Innovative Technology appointed.

What new product did Novella Innovative Technology launch?

In September 2025, Novella Innovative Technology launched its Novella whole-cell strawberry ingredient at SSW.